What a difference a month makes in the never-boring world of weight-loss drugs. Last month—when the news was so bullish that semaglutides (or GLP-1s, as this class of drugs is known) such as Ozempic and Wegovy might also cure all addiction—Morgan Stanley analystsraise...
It also includes each organization’s top-selling drugs and R&D investment totals. While Big Pharma, by and large, remains a picture of strength and stability, highlighted, in some cases, by exponential and unprecedented financial growth, for the companies making up the Pharma 50, it has not ...
Labya concludes: “In light of the waning demand for COVID-19 products, the biopharmaceutical companies that reaped success in 2023 have shifted to those that have developed weight loss drugs, such as Lilly and Novo Nordisk. However, ot...
(NYSE:LLY) is one of the world's largestpharmaceutical companies. Its main revenue drivers are diabetes drugs, and it was the first company to mass-produce insulin and the polio vaccine. Eli Lilly also manufactures antidepressants, most notably Prozac, along with weight-loss drugs. And it's ...
Banking Mortgages Insurance Credit Monitoring Personal Finance Small Business Taxes Help for Low Credit Scores Investing USA INTL watch now Biden administration releases prices of 10 drugs in Medicare talks watch now AI models are becoming more specialized for industries, DeepL CEO says ...
Taxes Help for Low Credit Scores Investing USA INTL European SpaceX rival raises $160 million for reusable space capsule Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS watch now Merck KGaA continues focus on strengthening pipeline with innovation: CFO ...
Perhaps no drug maker captured public attention in the past year more thanNovo Nordisk, whose game-changing diabetes and anti-obesity drugs Ozempic and Wegovy saw prescriptions surge and revenue soar, driven primarily by insatiable U.S. demand. But even more significant, ongoing studies of these ...
Buyers and Sellers in the Weight Loss M&A Market:Without Buying and Selling, There's No Reshuffle New Pathways for Innovation and Transformation of Local Pharmaceutical Companies Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global ...
Buyers and Sellers in the Weight Loss M&A Market:Without Buying and Selling, There's No Reshuffle New Pathways for Innovation and Transformation of Local Pharmaceutical Companies Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global ...
Negotiations at advanced stage between French and Swiss companies that provide certification services to industry Europe Express European industry chief warns tariffs should be ‘something of the past’Premiumcontent Also in this newsletter: How Brussels wants to retrain car industry workers ...